{"id":54544,"date":"2023-03-06T21:05:42","date_gmt":"2023-03-06T20:05:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/"},"modified":"2023-03-06T21:05:42","modified_gmt":"2023-03-06T20:05:42","slug":"viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/","title":{"rendered":"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing"},"content":{"rendered":"
\n

DENVER–(BUSINESS WIRE)–VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced today a strategic collaboration with Exact Sciences, a leading provider of cancer screening and diagnostic tests, to improve access to precision oncology diagnostics for patients and community oncologists within the United States.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nAs part of the agreement, VieCure will facilitate the integration and interpretation of Exact Sciences\u2019 growing portfolio of diagnostic tests into the clinical workflow of its oncology care management platform at the community oncology level, starting with the Oncotype DX\u00ae<\/sup> Breast Recurrence Score test. VieCure\u2019s proprietary artificial intelligence (A.I.) platform, which prompts clinical rules and guidelines within its interface, will help clinicians interpret test results and provide patient-specific treatment plans.\n<\/p>\n

\n\u201cVieCure and Exact Sciences, together, are accelerating the adoption of precision oncology in the community cancer care setting,\u201d said Dr. Fred Ashbury, Chief Scientific Officer at VieCure. \u201cOur goal through this collaboration is to improve clinical workflow and make it easier for community oncologists to order the right tests and generate patient-specific treatment plans.\u201d\n<\/p>\n

\nPersonalizing cancer treatment to respond to the molecular profile of an individual\u2019s cancer is rapidly becoming the standard of care and leading to improved patient outcomes. Exact Sciences\u2019 tests provide critical diagnostic, prognostic, and therapeutic insights to inform patient-specific treatment plans. These data are complex, considerable, and can be difficult to access and interpret in the community oncology setting. Together, VieCure and Exact Sciences aim to help overcome the potential challenges clinicians face in managing the growing amount of genomic information required to care for patients and keep current with rapidly evolving medical guidelines.\n<\/p>\n

\n\u201cAt Exact Sciences, we know that cancer care is complex. Our growing portfolio of precision oncology tests helps doctors and patients determine the most effective treatment plan by providing actionable insights about the molecular makeup of a patient\u2019s specific cancer,\u201d said Brian Baranick, general manager of Precision Oncology for Exact Sciences. \u201cBy streamlining the workflow, our VieCure partnership will help accelerate access to our test portfolio for community oncologists and their patients.\u201d\n<\/p>\n

\nAbout VieCure<\/b>\n<\/p>\n

\nVieCure has developed a proprietary artificial intelligence informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The VieCure\u2122 platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient\u2019s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. VieCure was launched in 2015 and has contracted with leading community oncology centers and cancer care delivery networks including Alabama Cancer Care, the American Oncology Network, and Oncology Care Partners. Active implementation of the VieCure platform is occurring in network locations across the United States. For more information, please visit viecure.com<\/a> and connect with VieCure on LinkedIn<\/a>, Facebook<\/a>, Twitter<\/a>, Instagram<\/a>, and YouTube<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nVieCure, Inc.
\n
Hailey Hogue, Coordinator, Marketing and Social Media
\n
Hailey.Hogue@VieCure.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DENVER–(BUSINESS WIRE)–VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced today a strategic collaboration with Exact Sciences, a leading provider of cancer screening and diagnostic tests, to improve access to precision oncology diagnostics for patients and community oncologists within the United States. As part of the agreement, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54544","6":"format-standard","7":"category-industry"},"yoast_head":"\nVieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DENVER–(BUSINESS WIRE)–VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced today a strategic collaboration with Exact Sciences, a leading provider of cancer screening and diagnostic tests, to improve access to precision oncology diagnostics for patients and community oncologists within the United States. As part of the agreement, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-06T20:05:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230306005155\/en\/1729680\/21\/Picture1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing\",\"datePublished\":\"2023-03-06T20:05:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/\"},\"wordCount\":498,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005155\\\/en\\\/1729680\\\/21\\\/Picture1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/\",\"name\":\"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005155\\\/en\\\/1729680\\\/21\\\/Picture1.jpg\",\"datePublished\":\"2023-03-06T20:05:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005155\\\/en\\\/1729680\\\/21\\\/Picture1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005155\\\/en\\\/1729680\\\/21\\\/Picture1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/","og_locale":"en_US","og_type":"article","og_title":"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing - Pharma Trend","og_description":"DENVER–(BUSINESS WIRE)–VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced today a strategic collaboration with Exact Sciences, a leading provider of cancer screening and diagnostic tests, to improve access to precision oncology diagnostics for patients and community oncologists within the United States. As part of the agreement, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-06T20:05:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230306005155\/en\/1729680\/21\/Picture1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing","datePublished":"2023-03-06T20:05:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/"},"wordCount":498,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230306005155\/en\/1729680\/21\/Picture1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/","url":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/","name":"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230306005155\/en\/1729680\/21\/Picture1.jpg","datePublished":"2023-03-06T20:05:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230306005155\/en\/1729680\/21\/Picture1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230306005155\/en\/1729680\/21\/Picture1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving-patient-access-to-genomic-testing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VieCure and Exact Sciences Enter Strategic Collaboration Aimed at Improving Patient Access to Genomic Testing"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54544"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54544\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}